Table 1.

Baseline characteristics

	All subject N = 18	TPG < 12 n = 12	TPG ≥ 12 n = 6
Age	60.1 ± 13.6	59.1 ± 13.4	32.0 ± 15.0
BMI	32.1 ± 11.6	31.5 ± 11.6	33.4 ± 12.7
EF	23.4 ± 6.9	22.2 ± 6.9	26.0 ± 6.8
PCWP	21 [17,29]	22 [18,32]	21 [12, 23]
eGFR	48 [37, 59]	50 [40,60]	35 [30, 40]
Atrial fibrillation	7 (44)	5 (42)	2 (33)
Beta‐blocker	14 (89)	10 (83)	4 (67)
Hydralazine	2 (13)	1 (8.3)	1 (17)
Nitrate	2 (13)	1 (8.3)	1 (17)
MCA	10 (63)	6 (50)	4 (67)
Loop diuretic	15 (94)	11 (92)	4 (67)
Thiazide diuretic	5 (31)	3 (25)	2 (33)

BMI, body mass index; EF, ejection fraction; eGFR, estimated glomerular filtration rate; MCA, mineralocorticoid antagonist; PCWP, pulmonary capillary wedge pressure; TPG, trans‐pulmonary gradient.

Descriptive statistics summarizing baseline demographic, haemodynamic, and medication data in all patients and in groups defined by TPG ≥ 12. Data are presented as mean ± standard deviation when normally distributed and as median [interquartile range] when not normally distributed. Medication frequency is presented as number (percentage). Haemodynamic data were obtained at time of CardioMEMS implantation.